Pfizer Inc. (PFE)

25.85 +0.05 (+0.19%) USD  |  NYSE  |  Dec 12, 16:00
25.86 +0.01 (+0.04%) After-Hours: 20:00
More

Pfizer Research and Development Expense (Annual): 10.74B for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 4.624B
Vertex Pharmaceuticals, Inc. 3.630B
CorMedix, Inc. 3.942M
Viking Therapeutics, Inc. 101.64M
Arvinas, Inc. 348.20M